Investor Events

24 Sep 2024

Red Eye interview with CEO Anders Rylander

Watch the video here

 

19 Sept

Pareto Securities Healthcare Conference

Open presentation here

12 Sep 2024

Q1 Earnings call FY24/25

Watch the video here

Presenters were:
Anders Rylander, CEO
Anders Morén, CFO
Hector Tamburini, Head of US Operations
Henrik Winther, SVP Business Development

 

18 Jun 2024

Q4 Earnings call FY23/24

Presentation and written answers from the Q&A session: here

Presenters were:
Anders Rylander, CEO
Anders Morén, CFO
Hector Tamburini, Head of US Operations
Henrik Winther, SVP Business Development

 

24 Apr 2024

RedEye Interview

See the interview by RedEye journalist Johan Unnerus based on the announcement that Biovica is doing a cost reduction program in Sweden and the US!

 

10 Apr 2024

Invest in Oncology

See the presentation from the recent Investor Day by CORD Communications and financialhearings.com

 

To see the presentation: Click here

14 Mar 2024

Q3 Earningscall

Hear about the sales uptake in the US and our recent MSA Pharma contracts and order intake.

 

Please click the image to watch the recording!

8 Dec 2023

Carlsquare Investor Day

Carlsquare brought together Life Science investors for a day of presentations. 20 min + 10 min questions for each company participating. Here is the recording from our presentation.

 

Please click the image to watch the recording!

7 Dec 2023

CEO Interview

See the video interview – it’s in Swedish!

Biovica är i full gång med lanseringen av sitt cancertest DiviTum TKa för att bättre och snabbare prediktera och monitorera behandlingseffekt. Efter flertalet avtal i Europa och USA siktas på företrädesemission av units för att finansiera fortsatta marknadssatsningar. BioStock har pratat med vd Anders Rylander för att få hans tankar kring lansering och företrädesemissionen.

30 Nov 2023

RedEye Interview with senior management

Watch the Streaming from Nov 30th, 2023

28 Nov 2023

Q2 Earnings Call FY23/24

Download the presentation and watch the recording here: Biovica International AB – Financial reports

Presenters are:
Anders Rylander, CEO
Warren Cresswell, President of Americas
Henrik Winther, SVP Business Development
Anders Morén, CFO

27 Nov 2023

CEO Anders Rylander presents at STORA AKTIEDAGARNA

See the recording, where Aktiespararna brought together around 50 small and large Nordic companies for three packed days of investors presentations.

23 Nov 2023

CEO Anders Rylander at Redeye Life Science Day 2023 - Recording available

Redeye brought together 40+ Nordic companies for the Life Science Day, allowing investors, businesses, and experts co-create the industry’s future.

Watch our CEO Anders Rylander during the RedEeye discussions.

18 min Recording:  here

3 Oct 2023

Redeye Interview with Warren Cresswell, President of the Americas, Biovica

Discussion on pricing: Securing a Medicare (CMS) price for the US launch of our DiviTum® TKa test.
Redeye video

26 Sept 2023

Redeye Medtech & Diagnostics Seminar

Anders Rylander, CEO, presents (in Swedish) at the Redeye Medtech & Diagnostics Seminar

25 Sept 2023

RedEye Interview regarding Arizona agreement

Video interview with CEO Anders Rylander and President Americas Warren Cresswell

20 Sept 2023

Biovica Company Presentation 2023

14 Sept 2023

Pareto Securities' 14th Annual Healthcare Conference

CEO Anders Rylander presents
Presentation.pdf

6 Sept 2023

Q1 Earnings call 2023

Recorded event

22 May 2023

Trading Direkt Healthcare

Video interview with CEO Anders Rylander and President Americas Warren Cresswell:
Link to the interview on Redeye

2022

SEB Healthcare Seminar

Interview with Anders Rylander, CEO

28 November 2022

Stora Aktiedagen Stockholm

24 November 2022

Redeye Life Science Day

23 November 2022

Company Presentation

With CEO Anders Rylander

28 September 2022

Redeye Diagnostics Forum

With CEO Anders Rylander

13 of September 2022

ABGSC Investor Day

CEO Presentation

2 of September 2022

Redeye Theme: Late Stage Life Science 2022

Anders Rylander, CEO

1 September 2022

CEO interview by Redeye

With CEO Anders Rylander

31 August 2022

CEO presentation AGM

With CEO Anders Rylander

18 August 2022

Market update

FDA Clearance

19 May 2022

ABGSC Life Science Summit

Interview with Anders Rylander, CEO

17 May 2022

Capital Markets Day

8 December 2021

ABGSC Investor Day

With Anders Rylander, CEO

2021

Annual General Meeting

CEO’s presentation

May 2020

Redeye Diagnostics

August 2020

Company Presentation

2020

Redeye Interview with CEO Anders Rylander

CEO’s presentation

11th of May 2020

Biovica Capital Market Day

6 mars 2020

Nordnet Nordic Invest, Capital Markets Seminar

28 January 2020

Aktiedagen Lund

Aktiespararna

28 January 2020

Panelsamtal: Framtidens behandling av cancer på Aktiedagen

i Lund

24 January 2020

Pareto Securities life science analytiker går igenom Biovica

10 December 2019

Sitdown ABGSC Investor Days

4 november 2019

Stora Aktiedagen

i Göteborg

19 September 2019

Update on clinical development progress

Audiocast

5 September 2019

Pareto Securities’ 10th Annual Health Care Conference

in Stockholm

27 May 2019

Introduce Investor Days

April 2019

Management presentation directed issue

19 February 2019

Börsveckans Småbolagsdag Interview

29 January 2019

Biovica Stora Aktiedagen

December 2018

Introduce Investors Day

2018

Stora Aktiedagen

2018

ProHearings

June 2018

Småbolagsdagen

March 2018

Presentation Remium

September 2017

Presentation Remium

>4,500

Numbers of patients in studies

28

Publications

22

Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program

No